Clinical uses of contrast agents — practical considerations

[1]  A. Dell,et al.  Autoimmune determinants of rheumatic carditis: localization of epitopes in human cardiac myosin. , 1991, European heart journal.

[2]  J. Kisslo,et al.  Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. , 1991, Journal of the American College of Cardiology.

[3]  R. Petitclerc,et al.  Percutaneous mitral valvuloplasty in surgical high risk patients. , 1991, Journal of the American College of Cardiology.

[4]  S. Reisner,et al.  Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission. , 1990, Journal of the American College of Cardiology.

[5]  F J Ten Cate,et al.  Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. , 1990, Journal of the American College of Cardiology.

[6]  J R Shapiro,et al.  Reproducibility of quantitative myocardial contrast echocardiography. , 1990, Journal of the American College of Cardiology.

[7]  R. Schlief,et al.  Contrast echocardiographic examination of left heart chambers after intravenous injection of a new saccharide based contrast agent in humans , 1990 .

[8]  R. Schlief,et al.  Successful Opacification of the Left Heart Chambers on Echocardiographic Examination after Intravenous Injection of a New Saccharide Based Contrast Agent , 1990, Echocardiography.

[9]  J R Shapiro,et al.  Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans. , 1989, Journal of the American College of Cardiology.

[10]  S S Segal,et al.  The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. , 1989, Circulation research.

[11]  J. Elion,et al.  Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. , 1989, Journal of the American College of Cardiology.

[12]  S. Reisner,et al.  Prospects for transpulmonary contrast echocardiography. , 1989, Journal of the American College of Cardiology.

[13]  S. Reisner,et al.  Quantitative assessment of the immediate results of coronary angioplasty by myocardial contrast echocardiography. , 1989, Journal of the American College of Cardiology.

[14]  T. Kamada,et al.  Visualization of subendocardial myocardial ischemia with myocardial contrast echocardiography in humans. , 1989, Circulation.

[15]  S. Kaul,et al.  Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. , 1988, Journal of the American College of Cardiology.

[16]  D D Watson,et al.  Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve. , 1988, Journal of the American College of Cardiology.

[17]  M. S. Klein,et al.  Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity. , 1988, Journal of the American College of Cardiology.

[18]  M. Schlepper,et al.  Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echo contrast agent. , 1988, American heart journal.

[19]  R D Latham,et al.  Hemodynamics of the Mueller maneuver in man: right and left heart micromanometry and Doppler echocardiography. , 1987, Circulation.

[20]  S. Feinstein,et al.  Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. , 1987, American heart journal.

[21]  S. Kaul,et al.  Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography. , 1986, Journal of the American College of Cardiology.

[22]  S. Feinstein,et al.  Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. , 1986, Journal of the American College of Cardiology.

[23]  J. Roelandt,et al.  Myocardial perfusion imaging in humans by contrast echocardiography using polygelin colloid solution. , 1985, Journal of the American College of Cardiology.

[24]  C. Tei,et al.  Hyperemic response of intracoronary contrast agents during two-dimensional echographic delineation of regional myocardium. , 1984, Journal of the American College of Cardiology.

[25]  E. G. Tickner,et al.  The source of ultrasound contrast effect , 1980, Journal of clinical ultrasound : JCU.

[26]  R. Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[27]  S. Reisner,et al.  Contrast agents for myocardial perfusion studies , 1991 .

[28]  S. Reisner,et al.  28. Contrast agents for myocardial perfusion studies Mechanisms, state oj the art and future prospects , 1990 .

[29]  W. Roberts,et al.  Mode of death, frequency of healed and acute myocardial infarction, number of major epicardial coronary arteries severely narrowed by atherosclerotic plaque, and heart weight in fatal atherosclerotic coronary artery disease: analysis of 889 patients studied at necropsy. , 1990, Journal of the American College of Cardiology.

[30]  R. Meltzer,et al.  Myocardial Contrast Two-dimensional Echocardiography , 1989, Developments in Cardiovascular Medicine.

[31]  S. Kaul,et al.  Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  K. Schwarz,et al.  Sonication of echo-contrast agents: a standardized and reproductible method , 1988 .

[33]  R. Meltzer,et al.  Myocardial contrast two-dimensional echocardiography: dose-myocardial effect relations of intracoronary microbubbles. , 1988, Journal of the American College of Cardiology.

[34]  F J Ten Cate,et al.  Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. , 1984, Journal of the American College of Cardiology.

[35]  M. Fishbein,et al.  Two-dimensional contrast echocardiography. II. Transpulmonary studies. , 1984, Journal of the American College of Cardiology.

[36]  E. G. Tickner,et al.  Why do the lungs clear ultrasonic contrast? , 1980, Ultrasound in medicine & biology.